Search research articles
Contact Us
Filters
Showing results (31-40 of 47) with videos related to
Page
of 5
Sort By:
Annals of Surgical Oncology
|
August 15, 2019
Evaluation of Surgical Disparities Between African American and European American Women Treated for Breast Cancer Within an Equal-Access Military Hospital
Leann A Lovejoy, Yvonne L Eaglehouse, Matthew T Hueman, et al.
The Journal of Biological Chemistry
|
September 28, 2007
Identification of human T cell leukemia virus type 1 tax amino acid signals and cellular factors involved in secretion of the viral oncoprotein
Pooja Jain, Kate Mostoller, Katherine E Flaig, et al.
Clinical Pharmacology in Drug Development
|
June 9, 2019
Thorough QTc Evaluation and the Safety of Supratherapeutic Doses of Odanacatib in Healthy Subjects
Jacqueline McCrea, Kate Mostoller, Chantal Mahon, et al.
American Journal of Infectious Diseases
|
March 31, 2010
Molecular Mechanisms of Neurodegenerative Diseases Induced by Human Retroviruses: A Review
Bryan P Irish, Zafar K Khan, Pooja Jain, et al.
The Journal of Clinical Endocrinology and Metabolism
|
November 27, 2013
Odanacatib, a selective cathepsin K inhibitor, demonstrates comparable pharmacodynamics and pharmacokinetics in older men and postmenopausal women
Matt S Anderson, Isaias Noel Gendrano, Chengcheng Liu, et al.
Diabetes, Obesity & Metabolism
|
August 18, 2017
Single-dose euglycaemic clamp studies demonstrating pharmacokinetic and pharmacodynamic similarity between MK-1293 insulin glargine and originator insulin glargine (Lantus) in subjects with type 1 diabetes and healthy subjects
Michael F Crutchlow, John S Palcza, Kate M Mostoller, et al.
Clinical Pharmacology and Therapeutics
|
December 10, 2021
Acute and Chronic Effects of Rifampin on Letermovir Suggest Transporter Inhibition and Induction Contribute to Letermovir Pharmacokinetics
Jonathan A Robbins, Karsten Menzel, Michael Lassman, et al.
Molecular Biology of the Cell
|
December 12, 2019
The extent of Ssa1/Ssa2 Hsp70 chaperone involvement in nuclear protein quality control degradation varies with the substrate
Ramon D Jones, Charisma Enam, Rebeca Ibarra, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
March 23, 2018
Preclinical to Human Translational Pharmacology of the Novel M<sub>1</sub> Positive Allosteric Modulator MK-7622
Jason M Uslaner, Scott D Kuduk, Marion Wittmann, et al.
Research Square
|
November 19, 2025
Global human myeloid replacement with peripheral progenitors induces interferonopathy and neurodegeneration
Jing Wang, Anna Warden, Bing Xia, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 47) with videos related to
Sort By:
Page
of 5
Annals of Surgical Oncology
|
August 15, 2019
Evaluation of Surgical Disparities Between African American and European American Women Treated for Breast Cancer Within an Equal-Access Military Hospital
Leann A Lovejoy, Yvonne L Eaglehouse, Matthew T Hueman, et al.
The Journal of Biological Chemistry
|
September 28, 2007
Identification of human T cell leukemia virus type 1 tax amino acid signals and cellular factors involved in secretion of the viral oncoprotein
Pooja Jain, Kate Mostoller, Katherine E Flaig, et al.
Clinical Pharmacology in Drug Development
|
June 9, 2019
Thorough QTc Evaluation and the Safety of Supratherapeutic Doses of Odanacatib in Healthy Subjects
Jacqueline McCrea, Kate Mostoller, Chantal Mahon, et al.
American Journal of Infectious Diseases
|
March 31, 2010
Molecular Mechanisms of Neurodegenerative Diseases Induced by Human Retroviruses: A Review
Bryan P Irish, Zafar K Khan, Pooja Jain, et al.
The Journal of Clinical Endocrinology and Metabolism
|
November 27, 2013
Odanacatib, a selective cathepsin K inhibitor, demonstrates comparable pharmacodynamics and pharmacokinetics in older men and postmenopausal women
Matt S Anderson, Isaias Noel Gendrano, Chengcheng Liu, et al.
Diabetes, Obesity & Metabolism
|
August 18, 2017
Single-dose euglycaemic clamp studies demonstrating pharmacokinetic and pharmacodynamic similarity between MK-1293 insulin glargine and originator insulin glargine (Lantus) in subjects with type 1 diabetes and healthy subjects
Michael F Crutchlow, John S Palcza, Kate M Mostoller, et al.
Clinical Pharmacology and Therapeutics
|
December 10, 2021
Acute and Chronic Effects of Rifampin on Letermovir Suggest Transporter Inhibition and Induction Contribute to Letermovir Pharmacokinetics
Jonathan A Robbins, Karsten Menzel, Michael Lassman, et al.
Molecular Biology of the Cell
|
December 12, 2019
The extent of Ssa1/Ssa2 Hsp70 chaperone involvement in nuclear protein quality control degradation varies with the substrate
Ramon D Jones, Charisma Enam, Rebeca Ibarra, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
March 23, 2018
Preclinical to Human Translational Pharmacology of the Novel M<sub>1</sub> Positive Allosteric Modulator MK-7622
Jason M Uslaner, Scott D Kuduk, Marion Wittmann, et al.
Research Square
|
November 19, 2025
Global human myeloid replacement with peripheral progenitors induces interferonopathy and neurodegeneration
Jing Wang, Anna Warden, Bing Xia, et al.
Page
of 5